Volanesorsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS)

Summary

The purpose of this program is to provide expanded access to volanesorsen for up to 100 Patients with Familial Chylomicronemia Syndrome (FCS).

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications